日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection

自扩增 RNA 疫苗可保护小鼠免受致命埃博拉病毒感染

Verena Krähling, Stephanie Erbar, Alexandra Kupke, Sara S Nogueira, Kerstin C Walzer, Hendrik Berger, Erik Dietzel, Sandro Halwe, Cornelius Rohde, Lucie Sauerhering, Letícia Aragão-Santiago, Jorge Moreno Herrero, Sonja Witzel, Heinrich Haas, Stephan Becker, Ugur Sahin

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice

降低小鼠对mRNA疫苗的细胞固有免疫力会改变小鼠的适应性免疫反应。

Ziyin Wang ,Egon J Jacobus ,David C Stirling ,Stefanie Krumm ,Katie E Flight ,Robert F Cunliffe ,Jonathan Mottl ,Charanjit Singh ,Lucy G Mosscrop ,Leticia Aragão Santiago ,Annette B Vogel ,Katalin Kariko ,Ugur Sahin ,Stephanie Erbar ,John S Tregoning

A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity

诱导强效保护性免疫的反式扩增 RNA 疫苗策略

Tim Beissert, Mario Perkovic, Annette Vogel, Stephanie Erbar, Kerstin C Walzer, Tina Hempel, Silke Brill, Erik Haefner, René Becker, Özlem Türeci, Ugur Sahin

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

通过以自扩增mRNA形式递送的嵌合疫苗,可有效诱导针对HIV-1保守区域的T细胞。

Moyo, Nathifa; Vogel, Annette B; Buus, Søren; Erbar, Stephanie; Wee, Edmund G; Sahin, Ugur; Hanke, Tomáš

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses

自扩增 RNA 疫苗对流感的保护作用与 mRNA 疫苗相当,但剂量要低得多

Annette B Vogel, Laura Lambert, Ekaterina Kinnear, David Busse, Stephanie Erbar, Kerstin C Reuter, Lena Wicke, Mario Perkovic, Tim Beissert, Heinrich Haas, Stephen T Reece, Ugur Sahin, John S Tregoning

Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins

利用痘苗病毒免疫逃避蛋白改善自扩增 RNA 传递基因的体内表达

Tim Beissert, Lars Koste, Mario Perkovic, Kerstin C Walzer, Stephanie Erbar, Abderraouf Selmi, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Ugur Sahin

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles

通过在受感染细胞或病毒样颗粒上呈递选定的肿瘤相关抗原,实现抗原特异性溶瘤 MV 肿瘤疫苗

Stefan Hutzler, Stephanie Erbar, Robert A Jabulowsky, Jan R H Hanauer, Jürgen H Schnotz, Tim Beissert, Bianca S Bodmer, Regina Eberle, Klaus Boller, Thorsten Klamp, Ugur Sahin, Michael D Mühlebach

Nipah virus entry and egress from polarized epithelial cells.

尼帕病毒进入和离开极化上皮细胞

Lamp Boris, Dietzel Erik, Kolesnikova Larissa, Sauerhering Lucie, Erbar Stephanie, Weingartl Hana, Maisner Andrea

Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment.

尼帕病毒融合蛋白在 MDCK 细胞中的激活是由内体循环隔室内的组织蛋白酶 B 介导的

Diederich Sandra, Sauerhering Lucie, Weis Michael, Altmeppen Hermann, Schaschke Norbert, Reinheckel Thomas, Erbar Stephanie, Maisner Andrea

Nipah virus infection and glycoprotein targeting in endothelial cells.

尼帕病毒感染和内皮细胞中的糖蛋白靶向

Erbar Stephanie, Maisner Andrea